HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hua Zhu Selected Research

mouse Cxcl15 protein

7/2005Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hua Zhu Research Topics

Disease

147Neoplasms (Cancer)
12/2022 - 05/2002
48Infections
07/2022 - 03/2002
20Alzheimer Disease (Alzheimer's Disease)
01/2021 - 06/2006
19Neoplasm Metastasis (Metastasis)
01/2022 - 09/2009
19Breast Neoplasms (Breast Cancer)
01/2021 - 07/2004
18Inflammation (Inflammations)
01/2022 - 08/2002
13Wounds and Injuries (Trauma)
12/2022 - 06/2012
13Stomach Neoplasms (Stomach Cancer)
10/2022 - 01/2015
12Prostatic Neoplasms (Prostate Cancer)
04/2022 - 09/2014
12Carcinogenesis
01/2022 - 11/2008
12Hypoxia (Hypoxemia)
01/2022 - 08/2010
12Keratitis
11/2016 - 12/2002
11Ischemia
01/2022 - 06/2010
9Virus Diseases (Viral Diseases)
11/2021 - 09/2004
8Chickenpox
11/2022 - 07/2010
8COVID-19
07/2022 - 11/2020
8Insulin Resistance
01/2022 - 10/2009
7Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2012
7Herpes Zoster
11/2022 - 07/2010
7Cognitive Dysfunction
10/2022 - 11/2012
7Reperfusion Injury
01/2022 - 06/2014
7Adenocarcinoma
01/2022 - 10/2004
7Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 02/2015
7Carcinoma (Carcinomatosis)
01/2020 - 05/2002
7Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2019 - 01/2015
6Lung Neoplasms (Lung Cancer)
04/2022 - 01/2018
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2015
6Fibrosis (Cirrhosis)
01/2022 - 02/2014
5Hemorrhage
04/2022 - 12/2003
5Ischemic Stroke
01/2022 - 01/2014
5Brain Ischemia (Cerebral Ischemia)
01/2022 - 06/2010
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2009
5Pneumonia (Pneumonitis)
11/2021 - 01/2015
5Adenocarcinoma of Lung
01/2020 - 01/2015
5Necrosis
01/2018 - 10/2007
5Brain Injuries (Brain Injury)
01/2018 - 06/2010
5Sepsis (Septicemia)
11/2015 - 10/2005
4Stroke (Strokes)
10/2022 - 09/2014
4Infarction (Infarctions)
01/2022 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2017
4Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2008
4Cardiotoxicity
01/2021 - 02/2016
4Corneal Injuries
01/2021 - 01/2019
4Esophageal Squamous Cell Carcinoma
01/2020 - 06/2014
4Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2019 - 06/2014
4Thrombosis (Thrombus)
08/2019 - 12/2003
4Glioma (Gliomas)
01/2019 - 03/2009

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2002
25Biomarkers (Surrogate Marker)IBA
10/2022 - 07/2005
21VaccinesIBA
11/2022 - 07/2005
21Biological ProductsIBA
04/2020 - 05/2002
18AntigensIBA
04/2022 - 05/2002
15MicroRNAs (MicroRNA)IBA
01/2022 - 09/2008
15Messenger RNA (mRNA)IBA
01/2021 - 03/2002
13Peptides (Polypeptides)IBA
01/2022 - 09/2014
13Long Noncoding RNAIBA
01/2022 - 01/2015
11Pharmaceutical PreparationsIBA
12/2022 - 06/2014
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2009
11CytokinesIBA
11/2021 - 08/2002
10Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 01/2011
10Antiviral Agents (Antivirals)IBA
01/2020 - 11/2008
8ChemokinesIBA
01/2022 - 08/2002
8RNA (Ribonucleic Acid)IBA
01/2021 - 01/2010
7LigandsIBA
04/2022 - 07/2015
7Therapeutic UsesIBA
04/2022 - 01/2011
7Glycoproteins (Glycoprotein)IBA
01/2022 - 09/2009
6Radioisotopes (Radionuclides)IBA
01/2022 - 06/2017
6InterferonsIBA
01/2022 - 04/2005
6DNA (Deoxyribonucleic Acid)IBA
10/2020 - 09/2004
6Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2006
6Peptide Hydrolases (Proteases)FDA Link
02/2014 - 12/2002
5Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 01/2015
5Immune Checkpoint InhibitorsIBA
04/2022 - 11/2018
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022 - 01/2016
5Sorafenib (BAY 43-9006)FDA Link
01/2022 - 04/2015
51,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2022 - 01/2018
5CollagenIBA
01/2022 - 02/2014
5Melanins (Melanin)IBA
01/2021 - 12/2008
5Complement System Proteins (Complement)IBA
01/2021 - 08/2010
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2012
5AntibodiesIBA
12/2019 - 11/2014
5Insulin (Novolin)FDA Link
06/2016 - 10/2009
5Caveolin 1IBA
11/2008 - 07/2004
4Angiotensin-Converting Enzyme 2IBA
07/2022 - 10/2007
4AntioxidantsIBA
05/2022 - 01/2022
4Immunoglobulin G (IgG)IBA
01/2022 - 05/2002
4Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2021 - 03/2008
4OvalbuminIBA
06/2021 - 07/2005
4Trastuzumab (Herceptin)FDA Link
01/2021 - 11/2018
4EnzymesIBA
01/2021 - 03/2015
4Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021 - 06/2017
4EpitopesIBA
11/2020 - 01/2016
4Neutralizing AntibodiesIBA
01/2020 - 01/2014
4LipidsIBA
08/2019 - 10/2009

Therapy/Procedure

60Therapeutics
12/2022 - 07/2005
12Drug Therapy (Chemotherapy)
12/2022 - 02/2010
11Contact Lenses
01/2019 - 12/2002
8Immunotherapy
01/2022 - 07/2013
5Radiotherapy
01/2022 - 01/2018
4Transplantation
11/2019 - 05/2002